This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: University of Arkansas. Active years: 2017-2022.
Company Filing History:
Years Active: 2017-2022
Title: Innovations by Srinivas Jayanthi
Introduction
Srinivas Jayanthi is an accomplished inventor based in Fayetteville, AR (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered polypeptides. With a total of 4 patents to his name, Jayanthi's work focuses on enhancing the stability and effectiveness of growth factors used in medical treatments.
Latest Patents
Jayanthi's latest patents include innovative compositions and methods involving engineered FGF1 and FGF2 polypeptides. These engineered polypeptides are designed to be more stable than their wild-type counterparts, potentially improving their efficacy in treating various conditions, such as wound healing. His patents also cover the development of stable mutants of FGF-1 and FGF-2, along with pharmaceutical compositions and hydrogels that incorporate these novel polypeptides.
Career Highlights
Srinivas Jayanthi is affiliated with the University of Arkansas, where he conducts research and development in biotechnology. His work has garnered attention for its potential applications in medical therapies, particularly in enhancing the healing process through advanced growth factor compositions.
Collaborations
Jayanthi collaborates with notable colleagues, including Suresh Kumar Thallapuranam and David S McNabb. These partnerships contribute to the advancement of his research and the successful development of innovative solutions in the field.
Conclusion
Srinivas Jayanthi's contributions to biotechnology through his patents and research at the University of Arkansas highlight his role as a significant inventor in the field. His work on engineered growth factors promises to enhance medical treatments and improve patient outcomes.